TIZIANA LIFE SCIENCES

Pharmaceuticals and Biotechnology

EPIC: TILS

MARKET: AIM

WEBSITE: www.tizianalifesciences.com

All data delayed by at least 15 minutes.

Who are TIZIANA Life Sciences

Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biotechnology company that specializes in the developing transformative therapies for inflammatory diseases and cancer related to the liver. Our clinical pipeline includes drug assets for NASH, Crohn's, and hepatocellular carcinoma. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.

MEET THE TEAM

Tiziano Lazzaretti

Chief Financial Officer

Gabriele Cerrone

Executive Chairman

Kunwar Shailubhai PhD

CEO, CSO and Executive Director

Pello Capital do not accept any liability arising from any inaccuracy or omission in the information on the Tiziana website.
We advise you to verify the inaccuracy of any information before relying on it.

Latest News

Have your say….

Do you want to know more about TIZIANA Life Sciences?

Do you want to stay connected with the company?

Do you just want to have your say…..

Pello Spotlight will relay your comments back to TIZIANA Life Sciences and give you the

chance to stay connected.

LOG IN   OR   Sign Up   to accept and place an order

Cornhill Capital Limited offers investments and services to clients, which are primarily considered to be high risk investments. Some investments such as contracts for difference use leverage which can magnify gains but equally can magnify losses. Leveraged products may lose investors more than the amount they initially invested. This website is provided for information purposes only. It is not an offer to sell, or a solicitation of an offer to buy, any security, nor enter into any agreement or contract with Cornhill Capital Limited. All information provided is indicative and subject to market conditions and availability. Not all financial products are suitable for all investors. Before entering into any transaction you should ensure that you understand and have made an independent assessment of the suitability and appropriateness of the transaction into which you are entering and the nature and extent of your exposure to risk of loss in light of your own objectives, financial and operational resources and other relevant circumstances. You should take such independent investigations and such professional advice as you consider necessary or appropriate for such purpose. Past performance is no indicator of future success.